Cargando…

COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study

OBJECTIVE: The primary objectives were to determine the magnitude of COVID-19 infections in the general population and age-specific cumulative incidence, as determined by seropositivity and clinical symptoms of COVID-19, and to determine the magnitude of asymptomatic or subclinical infections. DESIG...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeedzai, Sayed Ataullah, Sahak, Mohammad Nadir, Arifi, Fatima, Abdelkreem Aly, Eman, van Gurp, Margo, White, Lisa J, Chen, Siyu, Barakat, Amal, Azim, Giti, Rasoly, Bahara, Safi, Soraya, Flegg, Jennifer A, Ahmed, Nasar, Ahadi, Mohmmad Jamaluddin, Achakzai, Niaz M, AbouZeid, Alaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334691/
https://www.ncbi.nlm.nih.gov/pubmed/35896297
http://dx.doi.org/10.1136/bmjopen-2021-060739
_version_ 1784759159446568960
author Saeedzai, Sayed Ataullah
Sahak, Mohammad Nadir
Arifi, Fatima
Abdelkreem Aly, Eman
van Gurp, Margo
White, Lisa J
Chen, Siyu
Barakat, Amal
Azim, Giti
Rasoly, Bahara
Safi, Soraya
Flegg, Jennifer A
Ahmed, Nasar
Ahadi, Mohmmad Jamaluddin
Achakzai, Niaz M
AbouZeid, Alaa
author_facet Saeedzai, Sayed Ataullah
Sahak, Mohammad Nadir
Arifi, Fatima
Abdelkreem Aly, Eman
van Gurp, Margo
White, Lisa J
Chen, Siyu
Barakat, Amal
Azim, Giti
Rasoly, Bahara
Safi, Soraya
Flegg, Jennifer A
Ahmed, Nasar
Ahadi, Mohmmad Jamaluddin
Achakzai, Niaz M
AbouZeid, Alaa
author_sort Saeedzai, Sayed Ataullah
collection PubMed
description OBJECTIVE: The primary objectives were to determine the magnitude of COVID-19 infections in the general population and age-specific cumulative incidence, as determined by seropositivity and clinical symptoms of COVID-19, and to determine the magnitude of asymptomatic or subclinical infections. DESIGN, SETTING AND PARTICIPANTS: We describe a population-based, cross-sectional, age-stratified seroepidemiological study conducted throughout Afghanistan during June/July 2020. Participants were interviewed to complete a questionnaire, and rapid diagnostic tests were used to test for SARS-CoV-2 antibodies. This national study was conducted in eight regions of Afghanistan plus Kabul province, considered a separate region. The total sample size was 9514, and the number of participants required in each region was estimated proportionally to the population size of each region. For each region, 31–44 enumeration areas (EAs) were randomly selected, and a total of 360 clusters and 16 households per EA were selected using random sampling. To adjust the seroprevalence for test sensitivity and specificity, and seroreversion, Bernoulli’s model methodology was used to infer the population exposure in Afghanistan. OUTCOME MEASURES: The main outcome was to determine the prevalence of current or past COVID-19 infection. RESULTS: The survey revealed that, to July 2020, around 10 million people in Afghanistan (31.5% of the population) had either current or previous COVID-19 infection. By age group, COVID-19 seroprevalence was reported to be 35.1% and 25.3% among participants aged ≥18 and 5–17 years, respectively. This implies that most of the population remained at risk of infection. However, a large proportion of the population had been infected in some localities, for example, Kabul province, where more than half of the population had been infected with COVID-19. CONCLUSION: As most of the population remained at risk of infection at the time of the study, any lifting of public health and social measures needed to be considered gradually.
format Online
Article
Text
id pubmed-9334691
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-93346912022-08-01 COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study Saeedzai, Sayed Ataullah Sahak, Mohammad Nadir Arifi, Fatima Abdelkreem Aly, Eman van Gurp, Margo White, Lisa J Chen, Siyu Barakat, Amal Azim, Giti Rasoly, Bahara Safi, Soraya Flegg, Jennifer A Ahmed, Nasar Ahadi, Mohmmad Jamaluddin Achakzai, Niaz M AbouZeid, Alaa BMJ Open Epidemiology OBJECTIVE: The primary objectives were to determine the magnitude of COVID-19 infections in the general population and age-specific cumulative incidence, as determined by seropositivity and clinical symptoms of COVID-19, and to determine the magnitude of asymptomatic or subclinical infections. DESIGN, SETTING AND PARTICIPANTS: We describe a population-based, cross-sectional, age-stratified seroepidemiological study conducted throughout Afghanistan during June/July 2020. Participants were interviewed to complete a questionnaire, and rapid diagnostic tests were used to test for SARS-CoV-2 antibodies. This national study was conducted in eight regions of Afghanistan plus Kabul province, considered a separate region. The total sample size was 9514, and the number of participants required in each region was estimated proportionally to the population size of each region. For each region, 31–44 enumeration areas (EAs) were randomly selected, and a total of 360 clusters and 16 households per EA were selected using random sampling. To adjust the seroprevalence for test sensitivity and specificity, and seroreversion, Bernoulli’s model methodology was used to infer the population exposure in Afghanistan. OUTCOME MEASURES: The main outcome was to determine the prevalence of current or past COVID-19 infection. RESULTS: The survey revealed that, to July 2020, around 10 million people in Afghanistan (31.5% of the population) had either current or previous COVID-19 infection. By age group, COVID-19 seroprevalence was reported to be 35.1% and 25.3% among participants aged ≥18 and 5–17 years, respectively. This implies that most of the population remained at risk of infection. However, a large proportion of the population had been infected in some localities, for example, Kabul province, where more than half of the population had been infected with COVID-19. CONCLUSION: As most of the population remained at risk of infection at the time of the study, any lifting of public health and social measures needed to be considered gradually. BMJ Publishing Group 2022-07-27 /pmc/articles/PMC9334691/ /pubmed/35896297 http://dx.doi.org/10.1136/bmjopen-2021-060739 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Saeedzai, Sayed Ataullah
Sahak, Mohammad Nadir
Arifi, Fatima
Abdelkreem Aly, Eman
van Gurp, Margo
White, Lisa J
Chen, Siyu
Barakat, Amal
Azim, Giti
Rasoly, Bahara
Safi, Soraya
Flegg, Jennifer A
Ahmed, Nasar
Ahadi, Mohmmad Jamaluddin
Achakzai, Niaz M
AbouZeid, Alaa
COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study
title COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study
title_full COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study
title_fullStr COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study
title_full_unstemmed COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study
title_short COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study
title_sort covid-19 morbidity in afghanistan: a nationwide, population-based seroepidemiological study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334691/
https://www.ncbi.nlm.nih.gov/pubmed/35896297
http://dx.doi.org/10.1136/bmjopen-2021-060739
work_keys_str_mv AT saeedzaisayedataullah covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT sahakmohammadnadir covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT arififatima covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT abdelkreemalyeman covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT vangurpmargo covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT whitelisaj covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT chensiyu covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT barakatamal covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT azimgiti covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT rasolybahara covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT safisoraya covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT fleggjennifera covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT ahmednasar covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT ahadimohmmadjamaluddin covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT achakzainiazm covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy
AT abouzeidalaa covid19morbidityinafghanistananationwidepopulationbasedseroepidemiologicalstudy